Britain’s economic outlook faced a big setback as the International Monetary Fund delivered its steepest downgrade for any ...

As President Trump prepares to announce pharmaceutical tariffs, he has one country, in particular, in his sights: Ireland.

In the meantime, have a read of Emma Hanrahan’s piece on the Kingspan chief receiving backing from investor advisory firm ...

Clonakility Distillery, dairy giant Ornua and machine-maker Edge Innovate in the crosshairs of disruptive policy programme ...

It was the second straight sizable increase, suggesting that U.S. drug makers with Irish manufacturing hubs like Indianapolis ...

Bad news for Pfizer (NYSE: PFE) turned into good news for Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Viking Therapeutics (NASDAQ: VKTX) Monday morning, each of which is rising on Pfizer ...

Eli Lilly LLY underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table encapsulates their recent ratings, offering a ...

ATLANTA, April 11, 2025 /PRNewswire/ -- On April 01, 2025, OrderlyMeds received a Cease-and-Desist letter from Eli Lilly regarding the compounding of Tirzepatide. This is our open response.

While US big tech usually dominates the headlines when it comes to Ireland ... including Eli Lilly and Gilead a short drive away in Kinsale and Carrigtwohill, Cork is home to 33 life science ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised ads and content, ad and content measurement, audience ...

In a report released today, Tim Anderson from Bank of America Securities maintained a Buy rating on Eli Lilly & Co (LLY – Research Report). The company’s shares closed yesterday at $726.24.